Dr. Shields is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 W 10th Ave
2nd Floor
Columbus, OH 43210Phone+1 614-293-6786Fax+1 614-293-1470- Is this information wrong?
Summary
- Dr. Peter Shields is an oncologist in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 34 years. He specializes in hematologic oncology and thoracic cancer and is experienced in hematologic oncology, public health, epidemiology, thoracic oncology, and cancer prevention.
Education & Training
- NIH Clinical CenterPost-Doctoral Fellowship, National Cancer Institute, 1987 - 1990
- George Washington UniversityFellowship, Hematology and Medical Oncology, 1987 - 1988
- George Washington UniversityResidency, Internal Medicine, 1983 - 1986
- Icahn School of Medicine at Mount SinaiClass of 1983
- University of PennsylvaniaBA, Biochemistry and American Civilization, Magna Cum Laude, 1979
Certifications & Licensure
- OH State Medical License 2012 - 2026
- VA State Medical License 1985 - 2016
- DC State Medical License 1985 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2017
- America's Top Doctors for Cancer Castle Connolly, 2005-2015
- Joseph Cullen Award American Society of Preventive Oncology, 2016
- Join now to see all
Clinical Trials
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
- Methods Project 4: Clinical Trial Start of enrollment: 2013 Jul 01
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Start of enrollment: 2015 Aug 17
- Join now to see all
Publications & Presentations
PubMed
- CLO24-061: Overall Survival (OS) Impact for NSCLC Patients With irAE and Non-irAE Hospital Admissions During First-Line Pembrolizumab Treatment.Adam Khorasanchi, Songzhu Zhao, Lai Wei, Mingjia Li, Kevin Ho, Hamzah Abu-Sbeih, Evelyn Goodyear, Austin Secor, Peter Shields, Kai He, Jacob Kaufman, Regan Memmott, As...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
- A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer.He, K., Terence M Williams, Eric Miller, Meng Welliver, Jeremy Brownstein, Gregory Otterson, Dwight Owen, Karl Haglund, Peter Shields, Erin Bertino, Carolyn Presley, K...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Feb 20
- Sex-specific lung inflammation and mitochondrial damage in a model of electronic cigarette exposure in asthma.Min-Ae Song, Ji Young Kim, Matthew W Gorr, Roy A Miller, Manjula Karpurapu, Jackie Nguyen, Devki Patel, Kellie J Archer, Navjot Pabla, Peter G Shields, Loren E Wold, J...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2023 Nov 1
- Join now to see all
Journal Articles
- Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer DatabaseKai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central
- Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognosesHaraldsdottir S, Hampel H, Wu C, Weng DY, Shields PG, Frankel WL, Pan X, de la Chapelle A, Goldberg RM, Bekaii-Saab T, Genet Med, 1/11/2016
- Genetic variation in one-carbon metabolism in relation to genome-wide DNA methylation in breast tissue from healthy womenSong MA, Brasky TM, Marian C, Weng DY, Taslim C, Llanos AA, Dumitrescu RG, Liu Z, Mason JB, Spear SL, Kallakury BV, Freudenheim JL, Shields PG, Carcinogenesis, 1/9/2016
- Join now to see all
Books/Book Chapters
Press Mentions
- People Diagnosed with Lung Cancer Who Quit Smoking Early Have Better Lung Cancer Survival RatesMay 5th, 2023
- Identifying the Inflammatory Cells Behind Chemo BrainFebruary 28th, 2023
- Moderate Fitness Levels Produce Significantly Larger Immune Response in Breast Cancer SurvivorsApril 26th, 2022
- Join now to see all
Grant Support
- Increasing Minority Participation In Cancer Prevention And ControlNational Cancer Institute2008–2010
- Genotypic And Phenotypic Response Of Breast Epithelial Cells From WomenNational Center For Research Resources2008–2009
- University Of The District Of Columbia And The Lombardi*National Cancer Institute2003–2008
- Genotypic&Phenotypic Response Breast Epithelial Cells From Women- MammoplastyNational Center For Research Resources2007
- Laboratory Assessment Of Tobacco Use Behavior And Exposure To Toxins Among UsersNational Cancer Institute2007
- Genotypic And Phenotypic Response Of Breast Epithelial Cells From WomenNational Center For Research Resources2006–2007
- Molecular Epidemiology Of Secondary Lung CancerNational Cancer Institute2003–2007
- Genotypic And Phenotypic Response Of Breast Epithelial Cells From WomenNational Center For Research Resources2004
- Genetic Determinants Of Tobacco Smoke Exposure And HARMNational Center For Research Resources2004
- Udc/Lcc Partnership For Cancer Research TrainingNational Cancer Institute2001–2003
- Cancer Research TrainingNational Cancer Institute2001–2002
- Molecular Epidemiology Of Breast CancerNational Center For Research Resources1999–2002
- Core--Molecular GeneticsNational Cancer Institute1999–2002
- Biobehavioral Determinants Of Tobacco Exposure And HARMNational Cancer Institute1999–2002
- Molecular Epidemiology Of Human Lung CancerDivision Of Basic Sciences - Nci1999
- Molecular Epidemiology Of Human Breast CancerDivision Of Basic Sciences - Nci1999
- Development Of Methods For Human Molecular Dosimetry And Molecular EpidemiologyDivision Of Basic Sciences - Nci1999
Hospital Affiliations
- The OSUCCC - JamesColumbus, Ohio
- Ohio State University Wexner Medical CenterColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: